Photonics: shining a light on the future of healthcare

With increasing demand for healthcare innovation, Rosie Casey, Vice President of High Growth Companies & Life Sciences UK, IDA Ireland, explores the future of photonics in the medical healthcare industry and the necessary requirements...

A soft spot for stem cells helps cornea healing

New research led by scientists at Newcastle University, UK reveals a potential revolutionary way to treat eye injuries and prevent blindness - by softening the tissue hosting the stem cells which then helps repair...

A new approach to reduce the impact of ageing

For Newcastle University Professor Thomas Zglinicki the biggest challenge that lies ahead for medical researchers is tackling age-related multimorbidity, the incidence of people living with several long-term conditions at a time. The professor, who works...

Artificial Intelligence – Friend or foe?

Artificial intelligence has come a long way in recent years. Most people would be lost without their GPS systems and robots are already navigating battlefields and doing the housework while drones may soon be...

Blood oxygen levels could explain why memory loss is an early symptom of Alzheimer’s

The findings demonstrate how the brain’s memory centre operates at a ‘watershed’ making it especially vulnerable to damage Study suggests increasing blood flow in the hippocampus might be really effective at preventing...

Research looks at living with dementia

The work being done is not just about diagnosis, some of it focuses on improving the way sufferers and their carers live day to day with the condition. In that field, the UK Economic and...

New director takes the helm

Teesside University’s £22m National Horizons Centre opened last September with two objectives, to drive research into bioprocessing and to plug the yawning skills gap. Co-author of the UK’s National Industrial Biotechnology Strategy to 2030, Dr...

Making Pharmaceuticals person-specific

Dr Mohammed Maniruzzaman: Lecturer in Pharmaceutics and Drug Delivery at the University of Sussex In this issue of BioScience Today, we speak to Dr Mohammed Maniruzzaman, Lecturer in Pharmaceutics and Drug Delivery at the University of Sussex,...

Personalised medicine: driving a need for greater diversity

Kate Shaw, CEO of Innovative Trials, investigates one of the biggest challenges facing clinical research today. Personalised medicines, particularly gene and cell therapies, offer new opportunities for treating serious conditions such as muscular dystrophy, cystic fibrosis...

A global surveillance model is vital for future pandemic prevention

Broad viral surveillance is essential in pandemic prevention to allow for detection of potential threats and the immediate early launch of health protocols against pathogens. Yves Dubaquie, senior vice president of diagnostics, PerkinElmer, Inc.,...

Research offers hope to diabetes sufferers

The insulin-producing cells in the pancreas play a crucial role in the management of our blood sugar levels. If they don’t work properly, the body can no longer cope with glucose. New imaging techniques developed...

THE ROAD LESS TRAVELLED

A Women in Science event that took place in Newcastle upon Tyne’s Biosphere business incubator earlier this year certainly demonstrated that women are finally coming into their own in the fields of science, technology,...

Auto Injectors: Customer needs and future trends

Pharmaceutical industry might well be one of the most exacting industries on the market. In order to satisfy a very broad range of stakeholders, including patients, prescribers, payers, patient-care providers and other healthcare professionals,...

Taking cell AND gene therapy to the next level

The cell and gene therapy (CGT) sector urgently needs common standards. Open dialogue will help achieve the best outcomes for developers, manufacturers and - most importantly - the patients. Aloysius Chong, Project Director at...

A golden era for blood cancer treatments

It’s an exciting time in blood cancer research. As we deepen our understanding of the biology of blood cancer, researchers are developing better treatments than ever before, and we’re even beginning to talk about...

Zotefoams’ ZOTEK® F foam chosen by InsulFab for safe and effective delivery of COVID-19...

High-performance closed cell, crosslinked fluoropolymer foam helps ensure safe and secure transportation of ultra-cold chain vaccine As part of the USA’s Operation Warp Speed (OWS) initiative to combat the COVID-19 pandemic, Texas, USA-based InsulFab...